AU5779690A - Mutation of the rhinovirus system - Google Patents
Mutation of the rhinovirus systemInfo
- Publication number
- AU5779690A AU5779690A AU57796/90A AU5779690A AU5779690A AU 5779690 A AU5779690 A AU 5779690A AU 57796/90 A AU57796/90 A AU 57796/90A AU 5779690 A AU5779690 A AU 5779690A AU 5779690 A AU5779690 A AU 5779690A
- Authority
- AU
- Australia
- Prior art keywords
- mutation
- protease
- trans
- oligopeptides
- mutations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000035772 mutation Effects 0.000 title abstract 3
- 241000709661 Enterovirus Species 0.000 title 1
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1009—Picornaviridae, e.g. hepatitis A virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32711—Rhinovirus
- C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The present invention relates to systems which make it possible to introduce mutations in the VP1/2A and in the complete coding region of the 2A protease, to test systems with which the "cis" and "trans" activity can be investigated, to oligonucleotides which encode the mutations, and to the oligopeptides derived therefrom and to the use thereof, furthermore oligopeptides which are cleaved by the 2A protease into trans with different efficiency, and to the use thereof.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3920860 | 1989-06-25 | ||
DE3920860 | 1989-06-25 | ||
DE4018376 | 1990-06-08 | ||
DE4018376 | 1990-06-08 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU35245/93A Division AU657205B2 (en) | 1989-06-25 | 1993-03-16 | Mutation of the rhinovirus system |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5779690A true AU5779690A (en) | 1991-01-03 |
AU644078B2 AU644078B2 (en) | 1993-12-02 |
Family
ID=25882343
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU57796/90A Ceased AU644078B2 (en) | 1989-06-25 | 1990-06-25 | Mutation of the rhinovirus system |
AU35245/93A Ceased AU657205B2 (en) | 1989-06-25 | 1993-03-16 | Mutation of the rhinovirus system |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU35245/93A Ceased AU657205B2 (en) | 1989-06-25 | 1993-03-16 | Mutation of the rhinovirus system |
Country Status (16)
Country | Link |
---|---|
EP (2) | EP0410147B1 (en) |
JP (1) | JPH04503608A (en) |
KR (1) | KR920701439A (en) |
AT (1) | ATE114717T1 (en) |
AU (2) | AU644078B2 (en) |
CA (1) | CA2019661A1 (en) |
DE (2) | DE59007818D1 (en) |
DK (1) | DK0410147T3 (en) |
ES (1) | ES2064537T3 (en) |
FI (1) | FI903144A0 (en) |
GR (1) | GR3015192T3 (en) |
IE (2) | IE950434L (en) |
IL (2) | IL94841A0 (en) |
NO (1) | NO902789L (en) |
NZ (1) | NZ234212A (en) |
PT (1) | PT94458B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318423B2 (en) | 2004-07-06 | 2012-11-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting rhinoviruses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263903A1 (en) * | 1986-10-10 | 1988-04-20 | E.I. Du Pont De Nemours And Company | Method for preparing specific inhibitors of virus-specified proteases |
EP0321973B1 (en) * | 1987-12-23 | 1993-11-03 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Expression of the virally encoded protease P2A of HRV2 |
-
1990
- 1990-06-21 FI FI903144A patent/FI903144A0/en not_active IP Right Cessation
- 1990-06-22 IE IE950434A patent/IE950434L/en unknown
- 1990-06-22 PT PT94458A patent/PT94458B/en not_active IP Right Cessation
- 1990-06-22 CA CA002019661A patent/CA2019661A1/en not_active Abandoned
- 1990-06-22 IE IE227090A patent/IE66395B1/en not_active IP Right Cessation
- 1990-06-22 IL IL94841A patent/IL94841A0/en unknown
- 1990-06-22 NO NO90902789A patent/NO902789L/en unknown
- 1990-06-25 AT AT90112064T patent/ATE114717T1/en not_active IP Right Cessation
- 1990-06-25 AU AU57796/90A patent/AU644078B2/en not_active Ceased
- 1990-06-25 EP EP90112064A patent/EP0410147B1/en not_active Expired - Lifetime
- 1990-06-25 DE DE59007818T patent/DE59007818D1/en not_active Expired - Fee Related
- 1990-06-25 ES ES90112064T patent/ES2064537T3/en not_active Expired - Lifetime
- 1990-06-25 NZ NZ234212A patent/NZ234212A/en unknown
- 1990-06-25 EP EP93120518A patent/EP0602687A1/en not_active Withdrawn
- 1990-06-25 DE DE4020211A patent/DE4020211A1/en not_active Withdrawn
- 1990-06-25 DK DK90112064.2T patent/DK0410147T3/en active
- 1990-06-25 JP JP2509375A patent/JPH04503608A/en active Pending
-
1991
- 1991-02-25 KR KR1019910700212A patent/KR920701439A/en not_active Application Discontinuation
-
1993
- 1993-03-16 AU AU35245/93A patent/AU657205B2/en not_active Ceased
-
1995
- 1995-02-01 IL IL11250795A patent/IL112507A0/en unknown
- 1995-02-27 GR GR950400402T patent/GR3015192T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE66395B1 (en) | 1995-12-27 |
DK0410147T3 (en) | 1995-03-13 |
DE4020211A1 (en) | 1991-01-17 |
IE950434L (en) | 1990-12-25 |
IL94841A0 (en) | 1991-04-15 |
FI903144A0 (en) | 1990-06-21 |
IE902270L (en) | 1990-12-25 |
WO1991000348A1 (en) | 1991-01-10 |
PT94458A (en) | 1991-02-08 |
NZ234212A (en) | 1993-03-26 |
JPH04503608A (en) | 1992-07-02 |
DE59007818D1 (en) | 1995-01-12 |
WO1991000348A3 (en) | 2004-04-29 |
NO902789L (en) | 1990-12-27 |
EP0602687A1 (en) | 1994-06-22 |
AU3524593A (en) | 1993-05-27 |
GR3015192T3 (en) | 1995-05-31 |
ES2064537T3 (en) | 1995-02-01 |
AU644078B2 (en) | 1993-12-02 |
EP0410147B1 (en) | 1994-11-30 |
IL112507A0 (en) | 1995-05-26 |
IE902270A1 (en) | 1991-01-16 |
AU657205B2 (en) | 1995-03-02 |
PT94458B (en) | 1997-02-28 |
NO902789D0 (en) | 1990-06-22 |
EP0410147A1 (en) | 1991-01-30 |
ATE114717T1 (en) | 1994-12-15 |
CA2019661A1 (en) | 1990-12-25 |
KR920701439A (en) | 1992-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508981A (en) | Calcium-free subtilisin mutants | |
AU6414196A (en) | A modified enzyme with lipolytic activity | |
ZA91134B (en) | New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses | |
MX9606013A (en) | Phosphonyldipeptides useful in the treatment of cardiovascular diseases. | |
ATE77104T1 (en) | QUANTITY AND METHOD FOR MAKING HIGH YIELD RECOMBINATION PRODUCTS. | |
DE69930955D1 (en) | POLYPEPTIDES WITH LYSOPHOSPHOLIPASE ACTIVITY AND NUCLEIC ACIDS YOU CODE | |
JPS6485096A (en) | Hybrid human protein c and biotechnological synthesis thereof | |
IE822479L (en) | Dna molecules encoding certain mammalian proteins | |
DK0665882T3 (en) | DNA compounds comprising sequences encoding mannuronan C-5 epimerase | |
DK0418945T3 (en) | Branching enzyme and its use | |
NZ527971A (en) | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon | |
ES8704207A1 (en) | Rhinovirus strain HRV2 polypeptides and DNA molecules encoding them. | |
TR199802376T1 (en) | Oxalate Decarboxylase Coding Gen from Aspergillus Phoenices. | |
AU3524593A (en) | Mutation of the rhinovirus system | |
DE69934415D1 (en) | NEW COLLECTIN | |
NZ233672A (en) | Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence | |
HU0400487D0 (en) | Dna sequences coding for human ty protein related to interleukin-1 betha converting enzyme | |
ATE412751T1 (en) | HUMAN TAK1 AND DNA CODING FOR IT | |
ES2056123T3 (en) | CLONING OF THE GENE THAT CODES THE ENZYME ISOAMYLASE AND ITS USE IN THE PRODUCTION OF SUCH ENZYME. | |
TW342413B (en) | Novel toxins isolated from Bracon Hebetor | |
FI962047A0 (en) | Endothelin converting enzyme | |
YU29801A (en) | Prv-1 gene and the use thereof | |
RU96124779A (en) | DNA ENCODING BACILUS LICHENIFORMIS PWD-1 KERATINASE |